Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

CABA

CABA News

Newswire

04:21

Cabaletta Bio Advances Autoimmune Disease Treatment with Promising Clinical Results

04:21

Cabaletta Bio's Q3 Earnings Outshine Expectations, Bolstering Financial Health Amidst Volatility

07:37

Cabaletta Bio Reports Q3 Financial Results, Plans BLA Submission for Rese-cel in 2027.

07:35

Cabaletta Bio reports positive rese-cel data, planned BLA submission in 2027.

09:52

Cabaletta Bio: Cantor Fitzgerald raises PT to $30 from $15, maintains Overweight rating.

View More

About CABA

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More